Memorial Sloan Kettering Cancer Center MSK Pulmo-Oncology Symposium 2024
60 $
Format : 15 videos + 14 pdfs
File size: 3.13 GB
Date & Location
Friday, September 20, 2024, 7:55 AM – 5:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Specialties
Specialties – Bone Marrow Transplant, Cardiology, Emergency Medicine, General and Family Practice, Geriatric Medicine, Hematology, Hospice and Palliative Medicine, Hospitalist, Immunotherapy, Infectious Diseases, Integrative Medicine, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Pulmonology, Radiation Oncology, Respiratory Therapy, Sleep Medicine, Solid Tumor Oncology, Surgical Oncology, Thoracic Medical Oncology, Thoracic Surgery
Overview
Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement as well as by infections and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.
In this multidisciplinary symposium, clinical experts from Memorial Sloan Kettering (MSK) and around the world, will present an up-to-date overview on cutting edge cancer therapies and best practice strategies in the evaluation and management of lung disease. The purpose of this conference is to provide a state-of-the-art, case-based, multidisciplinary curriculum that addresses selected topics relevant to the respiratory health of patients with cancer.
The symposium offers participants the choice of attending either in person or virtually and is intended for healthcare professionals in pulmonology, hematology and oncology, and other disciplines involved in the care of cancer patients or who have a special interest in this area.
Objectives
At the conclusion of this symposium, attendees will be able to:
- Explain the role of the pulmonologist in diagnosis and management of lung cancer
- Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
- Implement strategies for diagnosis and management of infectious and non-infectious pulmonary complications of stem cell transplant
- Discuss multidisciplinary approach in complex patients.
- Explain the diagnosis and clinical significance of pre-existing interstitial lung abnormalities and interstitial lung disease in cancer management
+ Topics:
Case Presentation II.mp4
Case Presentation.mp4
Hypersensitivity Reactions to Cancer Treatments.mp4
Hypersensitivity Reactions to Cancer Treatments.pdf
ICI Pneumonitis- Second Line Treatment and Future Directions.mp4
ICI Pneumonitis- Second Line Treatment and Future Directions.pdf
Infections in the Immunocompromised Host.mp4
Infections in the Immunocompromised Host.pdf
IPF, Lung Cancer Surgery and Radiation- A Pulmonologist’s Perspective.mp4
IPF, Lung Cancer Surgery and Radiation- A Pulmonologist’s Perspective.pdf
New Drugs and Combos in Lung Cancer Land.mp4
New Drugs and Combos in Lung Cancer Land.pdf
Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.mp4
Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.pdf
Pulmonary Toxicity of Cancer Therapy.mp4
Pulmonary Toxicity of Cancer Therapy.pdf
PulmoOnc2024-Brochure.pdf
Role of Cryobiopsy in Diagnosis of Inflammatory Disease.mp4
Role of Cryobiopsy in Diagnosis of Inflammatory Disease.pdf
Role of Pulmonologist in Diagnosis and Management of Lung Cancer.mp4
Role of Pulmonologist in Diagnosis and Management of Lung Cancer.pdf
Strategies for the Mitigation of Radiation Pneumonitis and the Role of Multidisciplinary Collaboration- A Radiation Oncology’s Perspective.mp4
Strategies for the Mitigation of Radiation Pneumonitis and the Role of Multidisciplinary Collaboration- A Radiation Oncology’s Perspective.pdf
The Paradox of TB Reactivation on Immune Checkpoint Inhibitor Therapy. Too Much of a Good Thing.mp4
The Paradox of TB Reactivation on Immune Checkpoint Inhibitor Therapy. Too Much of a Good Thing.pdf
Updates on Surgical Management in Lung Cancer.mp4
Updates on Surgical Management in Lung Cancer.pdf
When Oncology Meets ILD- Background and Clinical Implication.mp4
When Oncology Meets ILD- Background and Clinical Implication.pdf
Be the first to review “Memorial Sloan Kettering Cancer Center MSK Pulmo-Oncology Symposium 2024”
You must be logged in to post a review.
Related Products
Reviews
There are no reviews yet.